Amarin Corp. (AMRN) option implied volatility elevated into sharp rally on release of patient study

Amarin Corp. (NASDAQ: AMRN) September weekly call option implied volatility is at 566, October is at 300; compared to its 52-week range of 35 to 428 into the release of an 8,000 patient study started in 2011 for their omega3 pill Vascepa.

You May Also Be Interested In

• SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
• Accelerant Holdings (ARX) 8500 contracts of July 15 calls active as share price up 8.7%
• AMD (AMD) call put ratio 1.4 calls to 1 put as share price down 4.3%